Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enalapril Maleate and Folic Acid Tablets for Prevention of Chronic Kidney Diseases in Patients With Hypertension: a Double-blind Randomized Controlled Trial

NCT01871740 is registered in ClinicalTrials.gov with Shenzhen Ausa Pharmed Co.,Ltd as lead sponsor.

NCT NCT01871740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01871740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enalapril Maleate and Folic Acid Tablets for Prevention of Chronic Kidney Diseases in Patients With Hypertension: a Double-blind Randomized Controlled Trial
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2008
Completion date
August 31, 2014
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperhomocysteinemia, hypertension